Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-05-21 @ 9:03 AM
Study NCT ID:
NCT01458067
Status:
COMPLETED
Last Update Posted:
2018-07-24
First Post:
2011-10-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
115717
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None